Project Grant S10OD030332

Award Date 6/15/21
Completion Date 6/14/22
Dollars Obligated $1.5M
Funding Federal Agency
Office of the Director
Federal Grant Program
93.351
Assistance Type
Project Grant
Place of Performance
Jupiter, FL 33458, USA
Similar Awards
This Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) provides $348,724 to Auburn University to acquire a new Liquid Chromatography-Quadrupole Time-of-Flight (LC-QTOF) mass spectrometer. The instrument will replace an outdated 15-year-old mass spectrometer, enabling high-resolution analysis of small molecules and biomolecules to support the research of at least 11 users, including 9 NIH-funded researchers, across...
This federal Project Grant award from the National Institutes of Health (NIH), under the Research Infrastructure Programs (CFDA 93.351), provides $949,116 to the University of South Florida (USF) to acquire a Thermo Fisher Scientific Orbitrap IQ-X mass spectrometer system with a Vanquish Flex UHPLC system. The instrument will establish a unique omics capability at USF to enable detailed, high-resolution structural analysis of low-level small molecules in complex biological matrices, with a focus...
This federal Project Grant award from the National Institutes of Health (NIH) Research Infrastructure Programs (CFDA 93.351) provides $1,089,778.00 to the University of Colorado Boulder (CU-Boulder) to acquire a high-resolution liquid chromatography-mass spectrometry system. The proposed instrument, a Waters Select Series Cyclic IMS QTOF mass spectrometer, will enable advanced small molecule and biomolecule analyses, including intact protein mass analysis, peptide mapping, and hydrogen-deuterium...
The National Institutes of Health (NIH) awarded a $1,352,820 Project Grant under the Research Infrastructure Programs (CFDA 93.351) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to acquire a novel Orbitrap Astral mass spectrometer. This high-performance mass spectrometer will enable high-throughput, high-sensitivity proteomics research focused on advancing the understanding and treatment of cancer and Alzheimer's disease. The grant, awarded on...
The National Science Foundation's Integrative Activities (CFDA 47.083) program has awarded a $350,000 Project Grant to the College of Charleston to acquire a MALDI-TOF/TOF mass spectrometer instrument. This state-of-the-art equipment will enable new research directions, encourage cross-disciplinary collaborations, and provide hands-on training for a diverse population of undergraduate students and researchers at the college and across the Lowcountry region of South Carolina. The mass...
This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351 - Research Infrastructure Programs) provides $250,000 to Montana State University Billings (MSUB) to acquire an Agilent 1290 Infinity Series II Ultra-High-Performance Liquid Chromatography (UHPLC) system integrated with a 6530 Quadrupole Time-of-Flight (QTOF) mass spectrometer. This cutting-edge analytical instrument will enable MSUB to conduct advanced biomedical...
The National Institutes of Health (NIH) awarded a $597,985 Project Grant under the Research Infrastructure Programs (CFDA 93.351) to Baylor College of Medicine to acquire a QTRAP 7500 hybrid quadrupole-linear ion trap mass spectrometer and Shimadzu UHPLC system. This state-of-the-art liquid chromatography-mass spectrometry (LC-MS) platform will expand the Baylor College of Medicine's bioanalytical capacity to support increasing levels of pediatric translational research across multiple...
The National Science Foundation Office of Integrative Activities awarded a $1,179,143 Project Grant to the University of New Hampshire (UNH) to acquire an Orbitrap Eclipse Tribrid mass spectrometer. This equipment will (i) dramatically improve UNH's mass spectrometry capabilities to expedite diverse research projects, (ii) facilitate hands-on training and inquiry-based learning on modern instrumentation, and (iii) establish a regional high-resolution mass spectrometry facility. The funding...
The National Institute of General Medical Sciences (NIGMS) awarded a $719,476 Project Grant under CFDA 93.859, Biomedical Research and Research Training, to the University of California, Irvine. The funding will be used to acquire a state-of-the-art MALDI-QTOF mass spectrometer for imaging mass spectrometry (MALDI IMS) to support multiple NIH-funded programs at the university. The high-speed, high-resolution instrument will enable spatial phenotyping of biomolecules, including proteins,...
The National Institutes of Health Office of the Director awarded Stanford University $3.8 million under the Research Infrastructure Programs grant program (CFDA 93.351) to acquire a new Orbitrap Tribrid mass spectrometry platform. For over 20 years, Stanford University Mass Spectrometry has served as the campus-wide shared proteomics resource, housing and maintaining mass spectrometry instruments to support numerous NIH-funded biomedical research projects spanning human development, degenerative...

SCIEX 6500+ QTRAP MASS SPECTROMETER - PROJECT SUMMARY/ABSTRACT THIS PROPOSAL SEEKS FUNDS TO PURCHASE A SCIEX 6500+ QTRAP MASS SPECTROMETER WITH INTEGRATED SCIEX M5 MICROFLOW UHPLC TO BECOME PART OF THE DRUG METABOLISM AND PHARMACOKINETIC (DMPK) CORE. THIS SYSTEM WILL BE USED TO QUANTITATE THE CONCENTRATION OF SMALL MOLECULES IN PLASMA AND TISSUE SAMPLES FROM MOUSE PHARMACOKINETIC STUDIES. THE SCIEX 6500 QTRAP IS IDEALLY SUITED TO THIS FUNCTION AND IS THE WORKHORSE INSTRUMENT FOR THE ANALYSIS OF PK SAMPLES IN PRE-CLINICAL LABORATORIES IN THE PHARMACEUTICAL INDUSTRY. THE SCRIPPS DMPK CORE RUNS OVER 200 MOUSE PK STUDIES PER YEAR AND, WHEN POSSIBLE, UTILIZES MICROSAMPLING TECHNIQUES. MICROSAMPLING REQUIRES SUPERIOR ANALYTICAL SENSITIVITY BECAUSE THE TECHNIQUE COLLECTS A LIMITED SAMPLE, 5-10 ML PLASMA. THE ADVANTAGE OF MICROSAMPLING IS THAT IT ALLOWS TRIPLICATE PK DATA TO BE GENERATED FROM THREE MICE, INSTEAD OF USING TWELVE OR TWENTY-FOUR MICE AS HAVE TRADITIONALLY BEEN REQUIRED. ANALYSIS OF MOUSE PHARMACOKINETIC SAMPLES IN THE SCRIPPS DMPK CORE IS CURRENTLY DONE ON A SCIEX 5500 MASS SPECTROMETER. MICROSAMPLING TECHNIQUES ARE CURRENTLY UTILIZED FOR APPROXIMATELY 80% OF THE COMPOUNDS TESTED AT THE SCRIPPS DMPK CORE. THE DECISION TO USE MICROSAMPLING OR REVERT TO A TRADITIONAL LARGE SAMPLE COLLECTION DESIGN USING HIGHER NUMBERS OF MICE IS BASED ON THE PLANNED DOSE AND AN EVALUATION OF THE ANALYTICAL LIMIT OF QUANTITATION, WHICH IS DETERMINED PRIOR TO CONDUCT OF THE IN-LIFE PORTION OF THE PK STUDY. THIS SHARED INSTRUMENTS CURRENTLY SUPPORTS A RANGE OF RESEARCH PROJECTS ORIGINATING FROM MULTIPLE NIH FUNDED PROJECTS ASSOCIATED WITH SEVEN INSTITUTIONS. THE LEVEL OF ENGAGEMENT FOR EACH OF THESE PROJECTS WITH THE DMPK CORE IS HIGH, AND THE CORE IS WRITTEN INTO MULTIPLE HIN FUNDED GRANTS. TO MAXIMIZE THE IMPACT OF NIHS INVESTMENT AND ASSURE THE INSTRUMENT REMAINS PRODUCTIVE FOR A PERIOD OF AT LEAST FIVE YEARS, SCRIPPS GUARANTEES MAINTENANCE AND OPERATIONAL COSTS, INCLUDING STAFF TO OVERSEE THE INSTRUMENT, AND WILL PURCHASE A SERVICE CONTRACT WITH THE INSTRUMENT MANUFACTURER THAT WILL COVER ALL REPAIRS AND YEARLY PREVENTATIVE MAINTENANCE FOR FIVE YEARS. THIS SHARED INSTRUMENT WILL BE INSTALLED IN THE SCRIPPS FLORIDA DMPK CORE AND WILL BE OPERATED BY A GROUP OF EXPERIENCED MASS SPECTROSCOPISTS WITHIN THE DMPK CORE.

Posted 6/10/21, 12:00 AM